immunotherapy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
immunotherapy
May 8, 2024, 13:50 |
Opinion
NCI Center for Cancer Research - Alka Dwivedi was honored in this year's list of TIME100 Most Influential in Health
NCI Center for Cancer Research shared a post on LinkedIn: "IN THE NEWS: If you haven't…
May 8, 2024, 07:02 |
Insight
Piotr Wysocki: Immunotherapy after chemotherapy may be the right choice
Piotr Wysocki recently shared on LinkedIn: "Mariniello A. et al. published results of an important preclinical…
May 8, 2024, 00:58 |
Blog
Stephen V Liu: Dr. Passiglia Fra at Rome Lung 24 illustrates the limited role of immunotherapy in driver positive NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 8, 2024, 00:50 |
Blog
Stephen V Liu: Dr. Giulia Pasello at Rome Lung 24 discusses duration of immunotherapy for NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 7, 2024, 10:39 |
Blog
Caryn Lerman: Saul Priceman will be the founding director of the new KSOM/USC Norris Center for Cancer Cellular Immunotherapy Research
Caryn Lerman, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared on LinkedIn:…
May 7, 2024, 06:28 |
Insight
Elisa Agostinetto: The long and winding road to biomarkers for immunotherapy
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared on LinkedIn: "The long and…
May 6, 2024, 19:10 |
Blog
Erman Akkus: ASCO Ed book on mNSCLC without oncogenic alterations
Erman Akkus, medical oncologist at Ankara Medical University, shared on Twitter/X: "Metastatic NSCLC without oncogenic…
May 6, 2024, 09:34 |
Insight
Piotr Wysocki: Striking activity of metronomic chemotherapy in a critically advanced cutaneous squamous cell cancer
Piotr Wysocki recently shared on LinkedIn: "In many countries, the availability of checkpoint inhibitors-based immunotherapy is…
May 5, 2024, 23:35 |
Blog
Raffaele Giusti: Withholding opioids for pain in immunotherapy patients?
Raffaele Giusti, Medical Oncologist at Sant'Andrea Hospital of Rome, made the following post on LinkedIn:…
May 5, 2024, 14:01 |
Blog
Maite Gorostegui: Our paper about Management of High-Risk Neuroblastoma in the Era of Anti-GD2 Immunotherapy
Maite Gorostegui, Pediatric Oncologist at Pediatric Cancer Center Barcelona, shared a post on LinkedIn: "We just…
1
2
3
4
5
All:
143
Posts:
1 - 10
Neuroendocrine tumors - newly updated AJCC guidelines
5 min Sarcoma Talk with Shushan Hovsepyan and Andrea Ferrari
OncoInfluencers: Dialogue with Tony Mok, hosted by Gevorg Tamamyan
New Paper Alert! Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma
Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment
Facebook
RSS Feed
Twitter
Linkedin
Youtube